Tirzepatide for Metabolic Dysfunction-Associated Steatohepatitis with Liver Fibrosis. - Loomba, R.; Hartman, M. L.; Lawitz, E. J.; Vuppalanchi, R.; Boursier, J.; Bugianesi, E.; Yoneda, M.; Behling, C.; Cummings, O. W.; Tang, Y.; Brouwers, B.; Robins, D. A.; et al. (New England Journal of Medicine, 2024)